These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. Khan A; Brodhead AE; Kolts RL; Brown WA J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562 [TBL] [Abstract][Full Text] [Related]
46. Suboptimal use of antidepressants in the elderly: a population-based study in Nova Scotia. Rojas-Fernandez C; Thomas VS; Carver D; Tonks R Clin Ther; 1999 Nov; 21(11):1937-50. PubMed ID: 10890265 [TBL] [Abstract][Full Text] [Related]
48. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness. Fitton A; Faulds D; Goa KL Drugs; 1992 Apr; 43(4):561-96. PubMed ID: 1377119 [TBL] [Abstract][Full Text] [Related]
49. Plasma drug levels and clinical response to antidepressants. Simpson GM; Pi EH; White K J Clin Psychiatry; 1983 May; 44(5 Pt 2):27-34. PubMed ID: 6343361 [TBL] [Abstract][Full Text] [Related]
50. Sensory profiles in unipolar and bipolar affective disorders: Possible predictors of response to antidepressant medications? A prospective follow-up study. Engel-Yeger B; Bloch B; Gonda X; Canepa G; Pompili M; Sher L; Rihmer Z; Amore M; Serafini G J Affect Disord; 2018 Nov; 240():237-246. PubMed ID: 30081295 [TBL] [Abstract][Full Text] [Related]
51. [Atypical depression: evolution toward a specific pharmacologic and efficacious treatment?]. Dassylva B; Fontaine R Can J Psychiatry; 1995 Mar; 40(2):102-8. PubMed ID: 7788612 [TBL] [Abstract][Full Text] [Related]
52. The medical consequences of the selection of an antidepressant. Nierenberg AA J Clin Psychiatry; 1992 Sep; 53 Suppl():19-24. PubMed ID: 1522076 [TBL] [Abstract][Full Text] [Related]
53. [Clinical and therapeutic evaluation of atypical antidepressants]. Panteleeva GP; Beliaev BS Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(10):115-9. PubMed ID: 2694699 [TBL] [Abstract][Full Text] [Related]
54. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related]
55. Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: can computational intelligence be used to augment clinical assessments? Athreya AP; Iyer R; Wang L; Weinshilboum RM; Bobo WV Pharmacogenomics; 2019 Sep; 20(14):983-988. PubMed ID: 31559920 [No Abstract] [Full Text] [Related]
56. Pharmacogenetics in the treatment of depression: pharmacodynamic studies. Serretti A; Artioli P; Quartesan R Pharmacogenet Genomics; 2005 Feb; 15(2):61-7. PubMed ID: 15861029 [TBL] [Abstract][Full Text] [Related]
57. Tranylcypromine in recurrent brief depression: two case reports. Joffe RT Int Clin Psychopharmacol; 1996 Dec; 11(4):287-8. PubMed ID: 9031997 [TBL] [Abstract][Full Text] [Related]
58. The new generation of antidepressants. Diab T; Singh AN Hosp Med; 2003 Jan; 64(1):12-5. PubMed ID: 12572328 [TBL] [Abstract][Full Text] [Related]